Personalised regional modelling predicts tau progression in the human brain

PLoS Biol. 2025 Jul 21;23(7):e3003241. doi: 10.1371/journal.pbio.3003241. eCollection 2025 Jul.

Abstract

Aggregation of the hyperphosphorylated tau protein is a central driver of Alzheimer's disease, and its accumulation exhibits a rich spatiotemporal pattern that unfolds during the course of the disease, sequentially progressing through the brain across axonal connections. It is unclear how this spatiotemporal process is orchestrated, namely, to what extent the spread of pathologic tau is governed by transport between brain regions, local production, or both. To address this, we develop a mechanistic model from tau PET data to describe tau dynamics along the Alzheimer's disease timeline. Our analysis reveals longitudinal changes in production and transport dynamics in two independent cohorts, with subjects in the early stage of the disease exhibiting transport-dominated spread, consistent with an initial spread of pathological tau seeds, and subjects in the late stage disease characterized primarily by local tau production. Further, we demonstrate that the model can predict accurately subject-specific longitudinal tau accumulation at the regional level, potentially providing a new clinical tool to monitor and classify patient disease progression.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Brain* / pathology
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phosphorylation
  • Positron-Emission Tomography
  • tau Proteins* / metabolism

Substances

  • tau Proteins
  • MAPT protein, human